Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma
Clinical trial NCT07336147 · RECRUITING
Trial details
- NCT number
- NCT07336147
- Sponsor
- Chang Gung Memorial Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2028-06-22
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.